Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Rosetta Genomics has collaborated with the Rabin Medical Center in Israel to develop microRNA-based diagnostics in the fields of oncology, gynecology, and obstetrics.
Subscribe to our email newsletter
The collaboration will leverage microRNAs’s significant potential as highly sensitive and specific biomarkers, to develop a wide range of diagnostic and prognostic tests. This is the company’s first collaboration to include a focus on diagnostics for women’s health indications.
Amir Avniel, president and CEO of Rosetta Genomics, said: “MicroRNAs’s unique characteristics as sensitive and specific biomarkers, coupled with our strong development engines, enable us to expand and advance our development programs outside the oncology field.”